These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Filed by the Registrant
☒
|
Filed by a Party other than the Registrant
☐
|
|
☐
|
Preliminary Proxy Statement
|
|
☐
|
Confidential, for Use of the Commission Only (As Permitted by Rule 14a-6(e)(2))
|
|
☒
|
Definitive Proxy Statement
|
|
☐
|
Definitive Additional Materials
|
|
☐
|
Soliciting Material Pursuant to §240.14a-12
|
|
☒
|
No fee required.
|
|
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
Total fee paid:
|
|
☐
|
Fee paid previously with preliminary materials.
|
|
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
Filing Party:
|
|
|
(4)
|
Date Filed:
|
|
(1)
|
To elect Thomas R. Schwarz and Bart C. Shuldman as directors to serve until the 2020 Annual Meeting of Stockholders or until the director's successor has been duly elected and qualified;
|
|
|
(2)
|
To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2017;
|
|
|
(3)
|
To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this Proxy Statement;
|
|
|
(4)
|
To approve an amendment to the Company's 2014 Equity Incentive Plan to increase the number of shares available for issuance; and
|
|
|
(5)
|
To transact such other business as may properly come before the Annual Meeting and any adjournment thereof.
|
|
|
By Order of the Board of Directors,
|
|
|
STEVEN A. DEMARTINO
Secretary
|
|
•
|
Proposal 1 – FOR the election of Thomas R. Schwarz and Bart C. Shuldman as directors of the Company;
|
|
•
|
Proposal 2 – FOR the ratification of the selection of PricewaterhouseCoopers LLP as an independent registered public accounting firm for 2017;
|
|
•
|
Proposal 3 – FOR the approval, on an advisory basis, of the compensation of our named executive officers as disclosed in this Proxy Statement; and
|
|
•
|
Proposal 4 – FOR the approval of an amendment to the Company's 2014 Equity Incentive Plan to increase the number of shares that are available for issuance.
|
|
Name of Beneficial Owner
|
Shares
Beneficially Owned |
Percent of
Class |
||||||
|
More than 5% Stockholders:
|
||||||||
|
Grand Slam Asset Management, LLC and
Mitchell Sacks (1)
|
596,658
|
8.12
|
%
|
|||||
|
The Vanguard Group (2)
|
388,490
|
5.29
|
%
|
|||||
|
Renaissance Technologies Holding Corporation (3)
|
387,001
|
5.27
|
%
|
|||||
|
Directors and Executive Officers:
|
||||||||
|
Graham Y. Tanaka (4)
|
276,350
|
3.73
|
%
|
|||||
|
Bart C. Shuldman (5)
|
228,238
|
3.04
|
%
|
|||||
|
Steven A. DeMartino (6)
|
206,996
|
2.76
|
%
|
|||||
|
Thomas R. Schwarz (7)
|
123,850
|
1.67
|
%
|
|||||
|
Andrew J. Hoffman (8)
|
55,125
|
*
|
||||||
|
Andrew J. Newmark (9)
|
48,540
|
*
|
||||||
|
John M. Dillon (10)
|
44,875
|
*
|
||||||
|
Tracey S. Chernay (11)
|
37,375
|
*
|
||||||
|
All current directors and executive officers as a group (9 persons) (12)
|
1,058,974
|
13.22
|
%
|
|||||
|
*
|
Less than 1% of the outstanding common stock.
|
|
(1)
|
This information listed in the table and this footnote is based solely on the Schedule 13G/A filed on February 2, 2017 by Grand Slam Asset Management, LLC ("GSAM") and Mitchell Sacks. According to the Schedule 13G/A, GSAM and Mitchell Sacks beneficially own 470,158 and 126,500 shares of our common stock, respectively. GSAM serves as the investment manager for a private investment fund with respect to which it has dispositive authority over the shares reported in the Schedule 13G/A. Mitchell Sacks is the Chief Investment Officer of GSAM with respect to which it has dispositive authority over the shares reported in the Schedule 13G/A. The address of GSAM and Mitchell Sacks is 2160 North Central Road, Suite 306, Fort Lee, NJ 07024.
|
|
(2)
|
This information listed in the table and this footnote is based solely on the Schedule 13G filed on February 10, 2017 by The Vanguard Group ("Vanguard"). Vanguard serves as the investment manager for a private investment fund with respect to which it has sole voting power and shared dispositive authority over 3,085 shares, and sole dispositive authority over 385,405 shares reported in Schedule 13G. The address of Vanguard is 100 Vanguard Boulevard, Malvern, PA 19355.
|
|
(3)
|
This information listed in the table and this footnote is based solely on the Schedule 13G filed on February 14, 2017 by Renaissance Technologies Holding Corporation ("Renaissance"). Renaissance serves as the investment manager for a private investment fund with respect to which it has shared dispositive authority over 31,556 shares, sole dispositive authority over 355,445 shares, and sole voting power over 352,277 shares reported in Schedule 13G, respectively. The address of Renaissance is 800 Third Avenue, New York, NY 10022.
|
|
(4)
|
Includes 66,875 shares subject to options currently exercisable or to become exercisable within 60 days of March 24, 2017 granted under the Company's 2005 Equity Incentive Plan and 2014 Equity Incentive Plan and 7,065 shares deemed beneficially owned by Mr. Tanaka that are directly owned by his children. Mr. Tanaka maintains margin securities accounts at brokerage firms, and the positions held in such margin accounts, which may from time to time include shares of common stock, are pledged as collateral security for the repayment of debt balances, if any, in the accounts. At March 24, 2017, Mr. Tanaka held 125,000 shares of common stock in such accounts.
|
|
(5)
|
Includes 1,500 shares owned by his spouse in an individual retirement account, 4,800 shares owned by his minor children and 3,750 shares owned by his mother. Includes 170,300 shares subject to options currently exercisable or to become exercisable within 60 days of March 24, 2017 granted under the Company's 2005 Equity Incentive Plan and 2014 Equity Incentive Plan. Also includes 36,074 deferred stock units issued under the Company's 2014 and 2015 Incentive Bonus Programs, which are fully vested and convertible into shares of common stock as of March 24, 2017.
|
|
(6)
|
Includes 146,425 shares subject to options currently exercisable or to become exercisable within 60 days of March 24, 2017 granted under the Company's 2005 Equity Incentive Plan and 2014 Equity Incentive Plan. Also includes 15,735 deferred stock units issued under the Company's 2014 and 2015 Incentive Bonus Programs, which are fully vested and convertible into shares of common stock as of March 24, 2017.
|
|
(7)
|
Includes 66,875 shares subject to options currently exercisable or to become exercisable within 60 days of March 24, 2017 granted under the Company's 2005 Equity Incentive Plan and 2014 Equity Inventive Plan. Also includes 1,500 shares deemed to be beneficially owned by Mr. Schwarz in his capacity as trustee of a trust for the benefit of his granddaughter, 1,500 shares beneficially owned by his daughter, as to which shares he disclaims beneficial ownership, and 2,000 shares owned by his spouse.
|
|
(8)
|
Includes 42,625 shares subject to options currently exercisable or to become exercisable within 60 days of March 24, 2017 granted under the Company's 2005 Equity Incentive Plan and 2014 Equity Incentive Plan.
|
|
(9)
|
Includes 7,375 shares subject to options currently exercisable or to become exercisable within 60 days of March 24, 2017 granted under the Company's 2014 Equity Incentive Plan.
|
|
(10)
|
Includes 34,375 shares subject to options currently exercisable or to become exercisable within 60 days of March 24, 2017 granted under the Company's 2005 Equity Incentive Plan and 2014 Equity Incentive Plan.
|
|
(11)
|
Includes 37,375 shares subject to options currently exercisable or to become exercisable within 60 days of March 24, 2017 granted under the Company's 2005 Equity Incentive Plan and 2014 Equity Incentive Plan.
|
|
(12)
|
Includes 661,409 deferred stock units and shares subject to options currently exercisable or to become exercisable within 60 days of March 24, 2017 granted under the Company's 2005 Equity Incentive Plan and 2014 Equity Incentive Plan.
|
|
•
|
Independent Judgment
.
The director must not have any relationship with the Company that, in the opinion of the Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In making this determination, the Board considers all relevant facts and circumstances, including commercial, charitable and familial relationships that might have an impact on the director's judgment.
|
|
•
|
Employment
. The director must not have been an employee of the Company or any parent or subsidiary of the Company at any time during the past three years. In addition, a member of the director's immediate family (including the director's spouse, parents, stepparents, children, stepchildren, siblings, mother-in-law, father-in-law, brother-in-law, sister-in-law, son-in-law, daughter-in-law and anyone who resides in the director's home other than a tenant or employee) must not have been an executive officer of the Company during the past three years.
|
|
•
|
Other Payments
. Neither the director nor a member of his or her immediate family may have received compensation of more than $120,000 from the Company during any period of twelve consecutive months during the past three years, except for director fees, payments arising solely from investments in the Company's securities, benefits under certain Company plans and non-discretionary compensation, certain permitted loans and compensation paid to a family member who is not an executive officer of the Company.
|
|
•
|
Auditor Affiliation
. Neither the director nor a member of his or her immediate family may be a current partner of the Company's independent auditors or have been a partner or employee of the Company's independent auditors who worked on the Company's audit at any time during the past three years.
|
|
•
|
Interlocking Directorships
. Neither the director nor any member of his or her immediate family may be employed as an executive officer by another entity where, at any time during the past three years, any of the Company's executive officers served on the compensation committee.
|
|
•
|
Transactions
. Neither the director nor any member of his or her immediate family may be a partner in, or a controlling stockholder or executive officer of, any organization that, during the current or any one of the past three years, received payments from the Company, or made payments to the Company, for property or services that exceed the greater of $200,000 or 5% of the recipient's annual consolidated gross revenues for such year (excluding payments arising solely from investments in the Company's securities or paid under a non-discretionary charitable matching program).
|
|
•
|
Additional Standards for Audit Committee Members
. Any director who serves on the Board's Audit Committee may not, directly or indirectly, have received any consulting, advisory or other compensatory fee from the Company (other than certain retirement benefits and deferred compensation) or be an affiliate of the Company (except as a director, but including by way of stock ownership). In addition, no such director may have participated in the preparation of the financial statements of the Company or any current subsidiary of the Company at any time during the past three years.
|
|
•
|
Specific Criteria
. The Nominating Committee and the Board review the overall composition of the Board in light of the Company's current and expected business needs and, as a result of such assessments, may establish specific qualifications that the Committee will seek in Board candidates.
|
|
•
|
Identifying New Candidates
. The Nominating Committee may seek to identify new candidates for the Board (i) who possess the desired qualifications and (ii) who satisfy the other requirements for Board service. In identifying new director candidates, the Committee may seek advice and names of candidates from Committee members, other members of the Board, members of management, and other public and private sources. The Committee may also, but need not, retain a search firm in order to assist in these efforts.
|
|
•
|
Reviewing New Candidates
.
The Nominating Committee reviews the potential new director candidates identified through this process. This involves reviewing the candidates' qualifications and conducting an appropriate background investigation. The Committee may also select certain candidates to be interviewed by one or more Committee members.
|
|
•
|
Reviewing Incumbent Candidates
. On an annual basis, the Nominating Committee also reviews incumbent candidates for re-nomination to the Board. This review involves an analysis of the criteria described above that apply to incumbent directors.
|
|
•
|
Recommending Candidates
. The Nominating Committee recommends a slate of candidates for the Board to submit for approval to the stockholders at the Annual Meeting. This slate of candidates may include both incumbent directors and new nominees. In addition, apart from this annual process, the Committee may, in accordance with the Corporate Governance Principles, recommend that the Board elect new members of the Board who will serve until the next annual meeting of stockholders. At the time of making any recommendation to the Board, the Committee reports on the criteria that were applied in making the recommendation and its findings concerning each candidate's qualifications.
|
|
•
|
Stockholder Nominations Submitted to the Committee
. Stockholders may also submit names of director candidates, including their own, to the Nominating Committee for its consideration. The process for stockholders to use in submitting suggestions to the Nominating Committee is set forth below under "Procedures for Submitting Director Nominations and Recommendations." Candidates who are nominated for the Board by stockholders are evaluated in the same manner as recommendations received from other sources.
|
|
2016
|
2015
|
|||||||
|
Audit Fees (1)
|
$
|
414,560
|
$
|
370,767
|
||||
|
Tax Fees (2)
|
3,213
|
4,029
|
||||||
|
All Other Fees (3)
|
1,818
|
1,818
|
||||||
|
Total Fees for Services Provided
|
$
|
419,591
|
$
|
376,614
|
||||
|
(1)
|
Audit Fees consist of fees related to: (i) the annual audit of the Company's financial statements
,
(ii) reviews of the Company's quarterly financial statements and the (iii) statutorily required audits for the Company's UK subsidiary.
|
|
(2)
|
Tax Fees consist of fees for the preparation of tax returns for our UK subsidiary.
|
|
(3)
|
All Other Fees include software license fees for the use of a web-based accounting research tool.
|
|
•
|
It has reviewed and discussed the audited financial statements, as well as the assessment of internal controls over financial reporting, with management.
|
|
•
|
It has discussed with the independent registered public accounting firm, which is responsible for expressing an opinion on the financial statements in accordance with generally accepted accounting principles, the matters required to be discussed by the statement on Auditing Standards No. 1301, "Communication with Audit Committees," as amended, as adopted by the Public Company Accounting Oversight Board in Rule 3200T.
|
|
•
|
It has received from the independent registered public accounting firm the written disclosures describing any relationships between the independent registered public accounting firm and the Company and the letter confirming their independence as required by applicable legal requirements of the Public Company Accounting Oversight Board and has discussed with the independent registered public accounting firm matters relating to their independence.
|
|
|
•
|
Based on its review and discussions described above, the Audit Committee recommended to the Board of Directors that the audited financial statements of the Company for the year ended December 31, 2016 be included in the Company's Annual Report on Form 10-K for filing with the SEC.
|
|
|
AUDIT COMMITTEE
|
||
|
John M. Dillon, Chair
|
||
|
Thomas R. Schwarz
|
||
|
Graham Y. Tanaka
|
||
|
|
•
|
|
Seeking alignment between short-term incentive metrics such as EBITDA and stock price and stockholder value over the long term.
|
|
|
•
|
|
Regular review of our executive compensation programs by our independent Compensation Committee and engagement of an independent compensation consultant, as necessary or appropriate.
|
|
|
•
|
|
Monitoring our programs against other companies in the marketplace with whom we compete for talent and against whom we measure our success, noting in particular that this group of companies may change rapidly as the Company experiences its own growth.
|
|
|
•
|
|
Engaging in rigorous talent reviews of our senior executives to ensure they remain committed to the Company's short and long-term goals, developing or obtaining the skills to manage in the current economy and preparing for the inevitable succession that naturally occurs in any organization.
|
|
|
•
|
|
Maintaining conservative benefit programs primarily directed and offered to all employees.
|
|
|
•
|
|
Providing executive officers nominal perquisites.
|
|
Plan category
|
(a)
Number of securities to be issued upon exercise / vesting of outstanding stock awards, warrants and rights |
(b)
Weighted average exercise price of outstanding options, warrants and rights |
(c)
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) |
|||||||||
|
Equity compensation plans approved by security holders:
|
||||||||||||
|
2005 Equity Incentive Plan
|
642,538
|
$
|
8.35
|
-
|
||||||||
|
2014 Equity Incentive Plan
|
549,234
|
7.21
|
25,816
|
|||||||||
|
Total
|
1,191,772
|
$
|
7.83
|
25,816
|
||||||||
|
•
|
Attract, engage, retain, and reward executive officers;
|
|
•
|
Motivate employees and encourage individual initiative and effort;
|
|
•
|
Help to achieve key business objectives and attain Company goals; and
|
|
•
|
Align executives' interests closely with those of the Company and its stockholders to drive long term sustainable earnings growth.
|
|
COMPENSATION AND CORPORATE
|
|
GOVERNANCE COMMITTEE
|
|
Thomas R. Schwarz, Chair
|
|
John M. Dillon
|
|
Graham Y. Tanaka
|
|
Name and Principal Position
|
Year
|
Salary ($)
|
Bonus (2)($)
|
Option
Awards (3)($) |
Stock
Awards (4)($) |
Non-Equity
Incentive Plan Compensation(5)($) |
All Other
Compensation ($) |
Total ($)
|
||||||||||||||||||||||
|
Bart C. Shuldman (1)
|
2016
|
498,698
|
-
|
160,066
|
227,334
|
300,000
|
43,507
|
(6)
|
1,229,605
|
|||||||||||||||||||||
|
Chairman and Chief
|
2015
|
493,232
|
-
|
108,500
|
-
|
469,803
|
42,627
|
(6)
|
1,114,162
|
|||||||||||||||||||||
|
Executive Officer
|
2014
|
489,917
|
-
|
248,404
|
-
|
369,924
|
43,033
|
(6)
|
1,151,278
|
|||||||||||||||||||||
|
Steven A. DeMartino
|
2016
|
330,527
|
-
|
50,041
|
71,461
|
132,956
|
23,172
|
(7)
|
608,157
|
|||||||||||||||||||||
|
President, Chief Financial
|
2015
|
322,707
|
-
|
86,800
|
-
|
204,919
|
23,116
|
(7)
|
637,542
|
|||||||||||||||||||||
|
Officer, Treasurer and Secretary
|
2014
|
320,900
|
-
|
74,521
|
-
|
161,353
|
22,797
|
(7)
|
579,571
|
|||||||||||||||||||||
|
Andrew J. Newmark (9)
|
2016
|
281,663
|
-
|
48,085
|
68,583
|
90,640
|
10,376
|
(8)
|
499,347
|
|||||||||||||||||||||
|
Executive Vice President,
|
2015
|
259,135
|
-
|
54,250
|
-
|
139,700
|
6,822
|
(8)
|
459,907
|
|||||||||||||||||||||
|
Sales & Marketing
|
2014
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||
|
Andrew J. Hoffman
|
2016
|
224,792
|
-
|
8,150
|
-
|
54,254
|
19,998
|
(7)
|
307,194
|
|||||||||||||||||||||
|
Senior Vice President
|
2015
|
218,245
|
-
|
21,700
|
-
|
83,620
|
19,920
|
(7)
|
343,485
|
|||||||||||||||||||||
|
Operations
|
2014
|
211,888
|
-
|
37,261
|
-
|
63,925
|
19,614
|
(7)
|
332,688
|
|||||||||||||||||||||
|
Tracey S. Chernay
|
2016
|
183,000
|
77,936
|
8,150
|
-
|
-
|
19,259
|
(7)
|
288,345
|
|||||||||||||||||||||
|
Senior Vice President
|
2015
|
183,000
|
86,881
|
16,275
|
-
|
-
|
18,805
|
(7)
|
304,961
|
|||||||||||||||||||||
|
Casino, Gaming & Lottery Sales
|
2014
|
183,000
|
65,467
|
37,261
|
-
|
-
|
18,466
|
(7)
|
304,194
|
|||||||||||||||||||||
|
(1)
|
Mr. Shuldman is a director of the Company, but does not receive any separate compensation for those services.
|
|
(2)
|
Bonuses paid to Mrs. Chernay represent commissions on casino and gaming annual sales.
|
|
(3)
|
Amounts reflect the grant date fair value of stock options, calculated in accordance with FASB ASC Topic 718, but excluding the effect of estimated forfeitures. The option award in 2014 was granted under the Company's 2005 Equity Incentive Plan and the option awards in 2015 and 2016 were granted under the Company's 2014 Equity Incentive Plan. For information on the valuation assumptions with respect to these awards, refer to the notes of the Company's financial statements in the Form 10-K for the years ended December 31, 2014, 2015 and 2016, as filed with the SEC. Please see the "Outstanding Equity Awards at 2016 Fiscal Year-End" table for a description of option awards. There were no forfeitures of stock compensation awards by this group during the year.
|
|
(4)
|
Amounts reflect the grant date fair value of RSUs and PSAs calculated in accordance with FASB ASC Topic 718 but excluding the effect of estimated forfeitures. These stock awards were granted under the Company's 2014 Equity Incentive. The grant date fair value of the PSAs assuming maximum performance achievement is as follows: Mr. Shuldman, $240,300; Mr. DeMartino, $75,294; and Mr. Newmark, $72,090.For information on the valuation assumptions with respect to the RSUs and PSAs reported in this column, refer to the notes of the Company's financial statements in the Form 10-K for the years ended December 31, 2016, as filed with the SEC. Please see the "Outstanding Equity Awards at 2016 Fiscal Year-End" table for a description of stock compensation awards. There were no forfeitures of stock compensation awards by this group during the year.
|
|
(5)
|
Amounts represent incentive cash bonuses earned under the Company's annual incentive cash bonus program. For Mr. Shuldman and Mr. DeMartino, for 2014 and 2015, 30% of these incentive bonus amounts were paid in the form of deferred stock units with the remainder paid in cash.
|
|
(6)
|
For Mr. Shuldman, this amount consists of an automobile allowance of $19,200, Company contributions under the Company's 401(k) Plan of $7,950, life insurance and disability insurance premiums of $12,007 and tax return preparation fees of $4,350.
|
|
(7)
|
For Mr. DeMartino, Mr. Hoffman and Mrs. Chernay, these amounts consist of automobile allowances of $12,000, $6,000 and $6,000, respectively, Company contributions under the Company's 401(k) Plan of $7,950 for Mr. DeMartino, Mr. Hoffman and Mrs. Chernay, life insurance and disability insurance premiums of $3,222, $6,048 and $5,309, respectively.
|
|
(8)
|
For Mr. Newmark, these amounts consist of Company contributions under the Company's 401(k) Plan of $7,950 and life insurance premiums of $2,426.
|
|
|
(7)
|
Mr. Newmark was hired as Executive Vice President, Sales and Marketing on January 12, 2015 at an annual base salary of $275,000.
|
|
Estimated Future Payouts Under Non-Equity Incentive Plan Awards (1)
|
||||||||||||
|
Name
|
Threshold ($)
|
Target ($)
|
Maximum ($)
|
|||||||||
|
Bart C. Shuldman
|
187,500
|
375,000
|
750,000
|
|||||||||
|
Steven A. DeMartino
|
83,097
|
166,194
|
332,388
|
|||||||||
|
Andrew J. Newmark
|
56,650
|
113,300
|
226,600
|
|||||||||
|
Andrew J. Hoffman
|
33,909
|
67,817
|
135,634
|
|||||||||
|
Tracey S. Chernay
|
-
|
-
|
-
|
|||||||||
|
(1)
|
Represents target payout under our annual incentive cash bonus program for 2016. Actual amounts paid in March 2017 for 2016 performance are included in the "Non-Equity Incentive Plan Compensation" column of the Summary Compensation Table. The maximum amounts assume a payout of 200% of the NEO's annual Target Bonus. The annual incentive cash bonus program is described in the "Compensation Discussion and Analysis".
|
|
Estimated Future Payouts Under Equity Incentive Plan Awards (1)
|
||||||||||||||||||||||||||||||
|
Name
|
Grant
Date |
Threshold ($)
|
Target ($)
|
Maximum ($)
|
All Other Stock Awards: Number of Units (2)(#)
|
All Other Option Awards: Number of Securities Underlying Options(3)(#)
|
Exercise or Base
Price of Option Awards ($/Sh) |
Grant Date Fair Value
of Stock and
Option Awards(4)($) |
||||||||||||||||||||||
|
Bart C. Shuldman
|
2/25/2016
|
-
|
-
|
-
|
16,800
|
-
|
-
|
107,184
|
||||||||||||||||||||||
| 2/25/2016 |
-
|
-
|
-
|
-
|
98,200
|
7.17
|
160,066
|
|||||||||||||||||||||||
|
|
4/28/2016
|
7,500
|
15,000
|
30,000
|
-
|
-
|
-
|
120,150
|
||||||||||||||||||||||
|
Steven A. DeMartino
|
2/25/2016
|
-
|
-
|
-
|
5,300
|
-
|
-
|
33,814
|
||||||||||||||||||||||
|
|
2/25/2016 |
-
|
-
|
-
|
-
|
30,700
|
7.17
|
50,041
|
||||||||||||||||||||||
|
|
4/28/2016 |
2,350
|
4,700
|
9,400
|
-
|
-
|
-
|
37,647
|
||||||||||||||||||||||
|
Andrew J. Newmark
|
2/25/2016
|
-
|
-
|
-
|
5,100
|
-
|
-
|
32,538
|
||||||||||||||||||||||
|
|
2/25/2016 |
-
|
-
|
-
|
-
|
29,500
|
7.17
|
48,085
|
||||||||||||||||||||||
|
|
4/28/2016 |
2,250
|
4,500
|
9,000
|
-
|
-
|
-
|
36,045
|
||||||||||||||||||||||
|
Andrew J. Hoffman
|
2/25/2016
|
-
|
-
|
-
|
-
|
5,000
|
7.17
|
8,150
|
||||||||||||||||||||||
|
Tracey S. Chernay
|
2/25/2016
|
-
|
-
|
-
|
-
|
5,000
|
7.17
|
8,150
|
||||||||||||||||||||||
|
(1)
|
Represents PSAs that were issued under our 2014 Equity Incentive Plan and are subject to vesting based on performance relative to two-year EBITDA targets. Each PSA corresponds to one share of common stock. Vesting ranges from a threshold payout of 50% of target to a maximum payout of 200%. Below threshold-level performance will result in a payout of 0% of target. Unvested PSAs do not accrue dividend equivalents. PSAs convert to common stock on a one-to-one basis upon vesting at the end of the performance period following the Compensation Committee's review and approval of performance achievement levels.
|
|
(2)
|
Represents RSUs that were issued under our 2014 Equity Incentive Plan. Unvested RSUs do not accrue dividend equivalents. Subject to the terms of our 2014 Equity Incentive Plan and the stock award agreements issued in connection with these grants, each RSU granted in 2016 to a NEO vests at a rate of 25% per year over four years and are settled in shares of common stock on a one-for-one basis.
|
|
(3)
|
Represents stock option awards that were issued under our 2014 Equity Incentive Plan and were granted with an exercise price per share equal to the fair market value of our common stock on the date of grant, as determined by the closing price of the stock on the date the option was granted. Subject to the terms of our 2014 Equity Incentive Plan and the option agreements issued in connection with these grants, each option award granted in 2016 to a NEO vests at a rate of 25% per year over four years.
|
|
(4)
|
The amounts shown represent the grant date fair value of stock awards granted in 2016 calculated in accordance with FASB ASC Topic 718, but excluding the effect of estimated forfeitures. The grant date fair values shown for PSAs granted to our NEOs assume target-level performance. For information on the valuation assumptions with respect to these awards, refer to note 11 of the Company's financial statements in the Form 10-K for the year ended December 31, 2016, as filed with the SEC. Please see the "Outstanding Equity Awards at 2016 Fiscal Year-End" table for a description of option awards. There were no forfeitures of stock option awards by this group during the year.
|
|
Option Awards
|
Stock Awards
|
|||||||||||||||||||||||||||||||
|
Grant Date
|
Number of
Securities Underlying Unexercised Options (# Exercisable)(2) |
Number of
Securities Underlying Unexercised Options (# Unexercisable) |
Option
Exercise Price ($) |
Option
Expiration Date |
Number Units of Stock That Have Not Vested(#)
|
Market Value of Units of Stock That Have Not Vested($)(3)
|
Number of Unearned Units That Have Not Vested(#)(4)
|
Payout Value of Unearned Units That Have Not Vested($)(3)
|
||||||||||||||||||||||||
|
Bart C. Shuldman (1)
|
-
|
-
|
-
|
|||||||||||||||||||||||||||||
|
2/28/2007
|
25,000
|
-
|
9.51
|
2/28/2017
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/27/2008
|
21,000
|
-
|
5.24
|
2/27/2018
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/5/2009
|
6,000
|
-
|
2.18
|
3/5/2019
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
5/27/2010
|
25,000
|
-
|
7.45
|
5/27/2020
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/7/2011
|
17,500
|
-
|
9.89
|
3/7/2021
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/5/2012
|
22,500
|
-
|
6.70
|
3/5/2022
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/1/2013
|
16,875
|
5,625
|
7.89
|
3/1/2023
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/27/2014
|
12,500
|
37,500
|
11.61
|
2/27/2024
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/26/2015
|
6,250
|
43,750
|
6.76
|
2/26/2025
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/25/2016
|
-
|
98,200
|
7.17
|
2/25/2026
|
16,800
|
110,880
|
-
|
-
|
||||||||||||||||||||||||
|
4/28/2016
|
-
|
-
|
-
|
-
|
-
|
-
|
15,000
|
99,000
|
||||||||||||||||||||||||
|
Steven A. DeMartino (1)
|
||||||||||||||||||||||||||||||||
|
2/28/2007
|
15,000
|
-
|
9.51
|
2/28/2017
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/27/2008
|
25,000
|
-
|
5.24
|
2/27/2018
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/5/2009
|
5,000
|
-
|
2.18
|
3/5/2019
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
5/27/2010
|
20,000
|
-
|
7.45
|
5/27/2020
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/7/2011
|
17,500
|
-
|
9.89
|
3/7/2021
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/5/2012
|
20,000
|
-
|
6.70
|
3/5/2022
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/1/2013
|
15,000
|
5,000
|
7.89
|
3/1/2023
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/27/2014
|
7,500
|
7,500
|
11.61
|
2/27/2024
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/26/2015
|
10,000
|
30,000
|
6.76
|
2/26/2025
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/25/2016
|
-
|
30,700
|
7.17
|
2/25/2016
|
5,300
|
34,980
|
-
|
-
|
||||||||||||||||||||||||
|
4/28/2016
|
-
|
-
|
-
|
-
|
-
|
-
|
4,700
|
31,020
|
||||||||||||||||||||||||
|
Andrew J. Newmark
|
||||||||||||||||||||||||||||||||
|
2/26/2015
|
-
|
25,000
|
6.76
|
2/26/2025
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/25/2016
|
-
|
29,500
|
7.17
|
2/25/2026
|
5,100
|
33,660
|
-
|
-
|
||||||||||||||||||||||||
|
4/28/2016
|
-
|
-
|
-
|
-
|
-
|
-
|
4,500
|
29,700
|
||||||||||||||||||||||||
|
Andrew J. Hoffman
|
||||||||||||||||||||||||||||||||
|
2/28/2007
|
7,500
|
-
|
9.51
|
2/28/2017
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/5/2009
|
2,000
|
-
|
2.18
|
3/5/2019
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
5/27/2010
|
1,250
|
-
|
7.45
|
5/27/2020
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/7/2011
|
5,000
|
9.89
|
3/7/2021
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||||
|
3/5/2012
|
15,000
|
6.70
|
3/5/2022
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||||
|
3/1/2013
|
5,625
|
1,875
|
7.89
|
3/1/2023
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/27/2014
|
3,750
|
3,750
|
11.61
|
2/27/2024
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/26/2015
|
2,500
|
7,500
|
6.76
|
2/26/2025
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/25/2016
|
-
|
5,000
|
7.17
|
2/25/2026
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
Tracey S. Chernay
|
||||||||||||||||||||||||||||||||
|
3/5/2009
|
3,000
|
-
|
2.18
|
3/5/2019
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
5/27/2010
|
1,250
|
-
|
7.45
|
5/27/2020
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/7/2011
|
10,000
|
-
|
9.89
|
3/7/2021
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/5/2012
|
5,000
|
-
|
6.70
|
3/5/2022
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
3/1/2013
|
5,625
|
1,875
|
7.89
|
3/1/2023
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/27/2014
|
3,750
|
3,750
|
11.61
|
2/27/2024
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/26/2015
|
1,875
|
5,625
|
6.76
|
2/26/2025
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
2/25/2016
|
-
|
5,000
|
7.17
|
2/25/2026
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
(1)
|
In addition to the stock options and awards reflected in the table above, Mr. Shuldman holds 42,106 fully vested deferred stock units and Mr. DeMartino holds 18,366 fully vested deferred stock units. These fully deferred stock units are payable upon the third anniversary of the grant date, or if earlier, a sale of the Company or the executive terminating employment with the Company for any reason, or on the third year anniversary of the grant date.
|
|||
|
(2)
|
The vesting schedule of the option awards reflected in the table are as follows:
|
|||
|
Grant Dates
|
Vesting Schedule
|
|||
|
2/28/2007, 2/27/2008, 3/5/2009
|
20% per year for five years
|
|||
|
5/27/2010, 3/7/2011, 3/5/2012, 5/30/12, 3/1/2013, 2/27/2014, 2/26/2015, 2/25/2016 (*)
|
25% per year for four years
|
|||
|
(*)
|
For the 50,000 stock option grants made to Mr. Shuldman on 2/27/14 and 2/26/2015, 25,000 options vest 25% per year for four years and 25,000 options vest 100% after five years. For the 25,000 stock option grants made to Mr. Newmark on 2/26/2015 the options vest 100% after four years.
|
|
(3)
|
Market value of RSUs and PSAs calculated by multiplying the number of unvested units using the closing price of $6.60 per share of our common stock on December 30, 2016, which was the last trading day of the year.
|
|
(4)
|
The number of shares shown for the PSAs granted in 2016 assumes target-level of performance based on estimates as of December 31, 2016. Actual payouts for these PSAs will be based on actual performance at the end of the two-year performance period.
|
|
|
Option Awards
|
Stock Awards
|
||||||||||||||
|
Name
|
Number of Shares Acquired On Exercise (#)
|
Value Realized on Exercise($)
|
Number of Shares Acquired on Vesting (1)(#)
|
Value Realized on Vesting(2)($)
|
||||||||||||
|
Bart C. Shuldman
|
-
|
-
|
12,264
|
$
|
91,857
|
|||||||||||
|
Steven A. DeMartino
|
-
|
-
|
5,349
|
40,064
|
||||||||||||
|
Andrew J. Newmark
|
-
|
-
|
-
|
-
|
||||||||||||
|
Andrew J. Hoffman
|
-
|
-
|
-
|
-
|
||||||||||||
|
Tracey S. Chernay
|
-
|
-
|
-
|
-
|
||||||||||||
|
(1)
|
Includes the underlying shares of the fully vested deferred stock units granted on March 1, 2013 to Mr. Shuldman and Mr. DeMartino under the 2005 Equity Incentive Plan, which are payable upon the third year anniversary from the date of grant in the form of shares of the Company's common stock on a one-for-one basis.
|
|
(2)
|
Amounts for shares underlying deferred fully vested stock units are calculated based on the market value of the Company's common stock on March 1, 2016, the third year anniversary from the date of grant.
|
|
Name
|
Stock
Awards (1) |
Option
Awards (2) |
Total
|
|||||||||
|
Bart C. Shuldman
|
$
|
487,780
|
$
|
55,080
|
$
|
542,860
|
||||||
|
Steven A. DeMartino
|
187,216
|
56,100
|
243,316
|
|||||||||
|
Andrew J. Newmark
|
63,360
|
-
|
63,360
|
|||||||||
|
Andrew J. Hoffman
|
-
|
8,840
|
8,840
|
|||||||||
|
Tracey S. Chernay
|
-
|
13,260
|
13,260
|
|||||||||
|
(1)
|
Accelerated deferred stock units, RSUs and PSAs were valued using the closing price of $6.60 per share of our common stock on December 30, 2016, which was the last trading day of the year. Upon a Change in Control Event, performance-based awards vest at target.
|
|
(2)
|
Accelerated stock options were valued using the spread between the exercise price of the applicable award and the closing price of $6.60 per share of our common stock on December 30, 2016, which was the last trading day of the year.
|
|
Name
|
Base
Salary |
Pro Rata
Portion of Annual Target Bonus |
Benefits(1)
|
Stock
Options |
Stock
Awards |
Total
|
||||||||||||||||||
|
Bart C. Shuldman
|
$
|
1,000,000
|
$
|
375,000
|
$
|
139,248
|
-
|
-
|
$
|
1,514,248
|
||||||||||||||
|
Steven A. DeMartino
|
332,389
|
166,195
|
44,918
|
-
|
-
|
543,502
|
||||||||||||||||||
|
Andrew J. Newmark (2)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
|
Andrew J. Hoffman
|
113,029
|
33,909
|
8,685
|
-
|
-
|
155,623
|
||||||||||||||||||
|
Tracey S. Chernay
|
91,500
|
-
|
9,409
|
-
|
-
|
100,909
|
||||||||||||||||||
|
(1)
|
Benefits were valued using the same assumptions that the Company uses for our financial reporting under generally accepted accounting principles, with the exception that the Company's cost of medical premiums is included here.
|
|
(2)
|
Mr. Newmark is not party to any agreement that would entitle him to any severance payments or benefits.
|
|
Name
|
Base
Salary |
Annual
Target Bonus |
Benefits(1)
|
Stock
Options (2) |
Stock
Awards (3) |
Total
|
||||||||||||||||||
|
Bart C. Shuldman
|
$
|
1,500,000
|
$
|
1,125,000
|
$
|
208,872
|
$
|
55,080
|
$
|
487,780
|
$
|
3,376,732
|
||||||||||||
|
Steven A. DeMartino
|
664,778
|
332,389
|
89,837
|
56,100
|
187,216
|
1,330,320
|
||||||||||||||||||
|
Andrew J. Newmark (4)
|
-
|
-
|
-
|
-
|
63,360
|
63,360
|
||||||||||||||||||
|
Andrew J. Hoffman
|
226,058
|
67,817
|
17,370
|
8,840
|
-
|
320,085
|
||||||||||||||||||
|
Tracey S. Chernay
|
183,000
|
-
|
18,819
|
13,260
|
-
|
215,079
|
||||||||||||||||||
|
(1)
|
Benefits were valued using the same assumptions that the Company uses for our financial reporting under generally accepted accounting principles, with the exception that the Company's cost of medical premiums is included here.
|
|
(2)
|
Accelerated stock options were valued using the spread between the exercise price of the applicable award and the closing price of $6.60 per share of our common stock on December 30, 2016, which was the last trading day of the year.
|
|
(3)
|
Accelerated deferred stock units, RSUs and PSAs were valued using the closing price of $6.60 per share of our common stock on December 30, 2016, which was the last trading day of the year.
|
|
(4)
|
Mr. Newmark is not party to any agreement that would entitle him to any severance payments or benefits.
|
|
Name
|
Fees Earned
Or Paid in Cash ($) |
Stock
Options(1)($) |
Stock
Awards (2)($) |
Total ($)
|
||||||||||||
|
John M. Dillon
|
$
|
40,000
|
$
|
18,300
|
$
|
15,720
|
$
|
74,020
|
||||||||
|
Thomas R. Schwarz
|
40,000
|
18,300
|
15,720
|
74,020
|
||||||||||||
|
Graham Y. Tanaka
|
40,000
|
18,300
|
15,720
|
74,020
|
||||||||||||
|
(1)
|
On February 25, 2016, Mr. Dillon, Mr. Schwarz and Mr. Tanaka were each awarded 7,500 stock options granted under the Company's 2014 Equity Incentive Plan. The amounts shown represent the grant date fair value of stock options granted in 2016 calculated in accordance with Compensation – Stock Compensation Topic of the FASB ASC, but excluding the effect of estimated forfeitures. For information on the valuation assumptions with respect to these awards, refer to note 11 of the Company's financial statements in the Form 10-K for the year ended December 31, 2016, as filed with the SEC. As of December 31, 2016, Mr. Dillon held 30,625 fully vested stock options at exercise prices ranging from $6.54 to $11.65 as well as 16,875 unvested stock options at exercise prices ranging from $6.54 to $10.06; Mr. Schwarz held 63,125 fully vested stock options at exercise prices ranging from $4.84 to $11.71 as well as 16,875 unvested stock options at exercise prices ranging from $6.54 to $10.06; Mr. Tanaka held 63,125 fully vested stock options at exercise prices ranging from $4.84 to $11.71 as well as 16,875 unvested stock options at exercise prices ranging from $6.54 to $10.06; and Mr. Shuldman held no stock option grants other than those shown in the "Outstanding Equity Awards at 2016 Fiscal Year-End" table above.
|
|
(2)
|
On April 28, 2016, Mr. Dillon, Mr. Schwarz and Mr. Tanaka were each awarded 2,000 RSUs granted under the Company's 2014 Equity Incentive Plan, all of which were unvested as of December 31, 2016. The RSUs vest at the rate of 25% per year beginning on the first anniversary of the date of grant. The amounts shown represent the grant date fair value of the RSUs granted in 2016 calculated in accordance with Compensation – Stock Compensation Topic of the FASB ASC, but excluding the effect of estimated forfeitures.
|
|
•
|
You are welcome to communicate anonymously or confidentially.
|
|
•
|
All correspondence addressed to an individual director or Committee Chair, and marked "Confidential", will be collected in the office of the Secretary and forwarded unopened to the individual director.
|
|
•
|
Other correspondence will be opened by the Secretary, reviewed, copied and directed as follows:
|
|
o
Concerns regarding the Company's accounting, internal accounting controls or auditing matters will be referred to the members of the Audit Committee.
|
|
|
o
Nominations or recommendations of candidates for election to the Board will be referred to members of the Nominating Committee.
|
|
o
Other correspondence will be copied by the Secretary and forwarded to all of the members of the Board (or its independent directors, if so addressed) unless the stockholder directs otherwise.
|
TRANSACT TECHNOLOGIES INCORPORATED
ONE HAMDEN CENTER
2319 WHITNEY AVENUE, SUITE 3B
HAMDEN, CT 06518
|
VOTE BY INTERNET - www.proxyvote.com
Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time on May 21, 2017. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.
Electronic Delivery of Future PROXY MATERIALS
If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:☒
|
KEEP THIS PORTION FOR YOUR RECORDS
|
|
DETACH AND RETURN THIS PORTION ONLY
|
|
For All
|
Withhold All
|
For All Except
|
To withhold authority to vote for any individual nominee(s), mark "For All Except" and write the number(s) of the nominee(s) on the line below.
|
|||||||
|
The Board of Directors recommends you vote FOR all of the nominees:
|
||||||||||
|
1.
|
ELECTION OF DIRECTORS
|
☐
|
☐
|
☐
|
||||||
|
Nominees
|
||||||||||
|
01
|
Thomas R. Schwarz
|
02 Bart C. Shuldman
|
||||||||
|
The Board of Directors recommends you vote FOR proposals 2, 3 and 4.
|
For
|
Against
|
Abstain
|
|||||||
|
2.
3.
4.
|
RATIFICATION OF THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2017.
APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
APPROVAL OF AN AMENDMENT TO THE 2014 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES THAT ARE AVAILABLE FOR ISSUANCE.
|
☐
☐
☐
|
☐
☐
☐
|
☐
☐
☐
|
||||||
|
NOTE:
Such other business as may properly come before the meeting or any adjournment thereof.
|
||||||||||
|
For address change/comments, mark here.
(see reverse side for instructions)
|
☐
|
|||||||||
|
Yes
|
No
|
|||||||||
|
Please indicate if you plan to attend this meeting
|
☐
|
☐
|
||||||||
|
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name, by authorized officer.
|
||||||||||
|
Signature [PLEASE SIGN WITHIN BOX]
|
Date
|
Signature (Joint Owners)
|
Date
|
|||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|